Here are three key notes:
1. Guided Therapeutics will sell 150 LuViva units and 275,000 Cervical Guides to the Turkish distributor in 2016.
2. LuViva is a diagnostic device that scans the cervix with light and utilizes spectroscopy to measure light interaction with cervical tissue. The device is designed to detect cervical disease.
3. Since April 2013, the company has sent more than 33 LuViva units and more than 14,500 disposable Cervical Guides to Turkey, resulting in about $588,000 in fully paid revenue.
“The Turkish MOH order provides a significant revenue base which we intend to grow by using our strategy of working with governments to implement or improve cervical cancer screening programs,” said Gene Cartwright, CEO, Guided Therapeutics.
Recent articles:
How much of ASC revenue is patients payments? 5 key trends in ASC patient billing
AmSurg retracts bid for TeamHealth, SCA launches new website & more — 4 key notes on ASC companies
Crane Creek Surgery Center joins First Choice Healthcare Medical Centers of Excellence Network: 5 things to know
